F-FDG PET and PET/CT for detection of pulmonary metastases from musculoskeletal sarcomas

Nuclear Medicine Communications

Volumn 27, Issue 10, 2006, Pages 795-802

  Iagaru, Andrei ^a   Chawla, Sant ^b   Menendez, Lawrence ^b   Conti, Peter S ^a  

^a PET Imaging Science Center   (Australia)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Lung; Metastases; PET CT; Sarcoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PATIENT; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL DISEASE; OSTEOSARCOMA; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY; SCHOOL CHILD; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SOFT TISSUE SARCOMA; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUSCLE NEOPLASMS; NEOPLASM METASTASIS; POSITRON-EMISSION TOMOGRAPHY; RADIOGRAPHY, THORACIC; RETROSPECTIVE STUDIES; SARCOMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33748746832     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/01.mnm.0000237986.31597.86     Document Type: Article

References (25)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, et al. Cancer statistics, 2005. CA Cancer J Clin 2005; 55:10-30.
2. Bastiaannet E, Groen H, Jager PL, Cobben DC, van der Graaf WT, Vaalburg W, et al. The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis. Cancer Treat Rev 2004; 30:83-101.
3. Franzius C, Daldrup-Link HE, Sciuk J, Rummeny EJ, Bielack S, Jurgens H, et al. FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT. Ann Oncol 2001; 12:479-486.
4. Conti PS, Feske WI, Grafton ST, Hayles SO, Menendez LR. Differentiation of benign from malignant primary bone and soft tissue lesions with PET. J Nucl Med 1996; 37:140P.
5. Jadvar H, Gamie S, Ramanna L, Conti PS. Musculoskeletal system. Semin Nucl Med 2004; 34:254-261.
6. Brisse H, Ollivier L, Edeline V, Pacquement H, Michon J, Glorion C, et al. Imaging of malignant tumors of the long bones in children: monitoring response to neoadjuvant chemotherapy and preoperative assessment. Pediatr Radiol 2004; 34:595-605.
7. Brenner W, Bohuslavizki KH, Eary JF. PET imaging of osteosarcoma. J Nucl Med 2003; 44:930-942.
8. Conti PS, Menendez LR, Ramanna L, Henderson RW. Use of positron emission tomography in the evaluation of cryosurgical treatment of musculoskeletal tumors. Radiology 1999; 213(P):118.
9. Sugawara Y, Zasadny KR, Neuhoff AW, Wahl RL. Reevaluation of the standardized uptake value for FDG: variations with body weight and methods for correction. Radiology 1999; 213:521-525.
10. Eary JF, O'Sullivan F, Powitan Y, Chandhury KR, Vernon C, Bruckner JD, et al. Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis. Eur J Nucl Med Mol Imaging 2002; 29:1149-1154.
11. Conrad EU 3rd, Morgan HD, Vernon C, Schuetze SM, Eary JF. Fluorodeoxyglucose positron emission tomography scanning: basic principles and imaging of adult soft-tissue sarcomas. J Bone Joint Surg Am 2004; 86-A(suppl 2):98-104.
12. Schulte M, Brecht-Krauss D, Werner M, Hartwig E, Sarkar MR, Keppler P, et al. Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET. J Nucl Med 1999; 40:1637-1643.
13. Schuetze SM, Rubin BP, Vernon C, Hawkins DS, Bruckner JD, Conrad EU 3rd, et al. Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy. Cancer 2005; 103:339-348.
14. 18F]-fluoro-2-deoxy-D-glucose in oncology. Part IIIb: Therapy response monitoring in colorectal and lung tumours, head and neck cancer, hepatocellular carcinoma and sarcoma. J Cancer Res Clin Oncol 2001; 127:278-285.
15. Franzius C, Sciuk J, Brinkschmidt C, Jurgens H, Schober O. Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis. Clin Nucl Med 2000; 25:874-881.
16. 18F-FDG-PET in the evaluation of bone and soft tissue sarcoma. J Nucl Med 2003; 44:75P.
17. Schwarzbach MH, Hinz U, Dimitrakopoulou-Strauss A, Willeke F, Cardona S, Mechtersheimer G, et al. Prognostic significance of preoperative [18-F] fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging in patients with resectable soft tissue sarcomas. Ann Surg 2005; 241:286-294.
18. Bredella MA, Caputo GR, Steinbach LS. Value of FDG positron emission tomography in conjunction with MR imaging for evaluating therapy response in patients with musculoskeletal sarcomas. Am J Roentgenol 2002; 179:1145-1150.
19. Schmall B, Conti PS, Bigler RE, Zanzonico PB, Reiman RE, Benua RS, et al. Imaging studies of patients with malignant fibrous histiocytoma using C-11-alpha-aminoisobutyric acid (AIB). Clin Nucl Med 1987; 12:22-26.
20. Hoegerle S, Juengling F, Otte A, Altehoefer C, Moser EA, Nitzche EU. Combined FDG and F-18 fluoride whole-body PET: a feasible two-in-one approach to cancer imaging? Radiology 1998; 209:253-258.
21. Fleming JB, Cantor SB, Varma DG, Holst D, Feig BW, Hunt KK, et al. Utility of chest computed tomography for staging in patients with T1 extremity soft tissue sarcomas. Cancer 2001; 92:863-868.
22. Porter GA, Cantor SB, Ahmad SA, Lenert JT, Ballo MT, Hunt KK, et al. Cost-effectiveness of staging computed tomography of the chest in patients with T2 soft tissue sarcomas. Cancer 2002; 94:197-204.
23. Picci P, Vanel D, Briccoli A, Talle K, Haakenaasen U, Malaguti C, et al. Computed tomography of pulmonary metastases from osteosarcoma: the less poor technique. A study of 51 patients with histological correlation. Ann Oncol 2001; 12:1601-1604.
24. Pitman AG, Hicks RJ, Binns DS, Ware RE, Kalff V, McKenzie AF, et al. Performance of sodium iodide based (18)F-fluorodeoxyglucose positron emission tomography in the characterization of indeterminate pulmonary nodules or masses. Br J Radiol 2002; 75:114-121.
25. Lucas JD, O'Doherty MJ, Wong JC, Bingham JB, McKee PH, Fletcher CD, et al. Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas. J Bone Joint Surg Br 1998; 80:441-447.